Adbelimumab plus famitinib malate and chemotherapy as second-line treatment for metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Interventions: experimental group:Adbelimumab+famitinib malate+chemotherapy Primary outcome(s): objective response rate Study Design: Single arm
创建时间：
2023-10-15
